alveoSenseAI™ · Made in India

Every test,
read like an expert.

The intelligence inside every alveofit device. It checks quality as the patient breathes, interprets against international standards, and shows its working. The doctor makes the call.

Three things, on every test.

01

Checks quality live

Each blow, breath or step is graded as it happens, so a poor test is repeated in the room, not discovered next week.

02

Interprets to standard

ATS/ERS 2019 and 2022, GLI-2012 and published oscillometry and walk-test references, applied the same way every time.

03

Shows its working

Every suggestion comes with the rule and the numbers behind it. The doctor reviews, edits and signs.

On every device

One intelligence. Tuned for each test.

alveoSenseAI™ adds to alveoAir Ultra

Live quality grading

ATS/ERS 2019 acceptability and repeatability graded on every blow, with coaching prompts while the patient is still in the chair.

GLI-2012 z-scores

Every value against GLI-2012 predicted, z-score and lower limit of normal, not just percent predicted.

Pattern detection

Obstruction, restriction and PRISm flagged, with bronchodilator response assessed on pre and post tests.

Explainable report

A decision trace on the report shows which rule fired and why, so the doctor can check the reasoning.

Built to be trusted

Explainable.
Standards-based.
Doctor in control.

alveoSenseAI™ is clinical decision support. It suggests, it explains, and it never signs a report on its own.

  • Explainable Every flag links to the rule and value that triggered it.
  • Standards-based Built on ATS/ERS, GLI-2012 and peer-reviewed references, not a black box.
  • Designed in India Developed by alveofit's clinical and engineering team in Pune, with Indian reference populations being added.
Spirometry · interpretationalveoSenseAI™
FEV1/FVC0.62z −2.1 · below LLN
FEV11.71 Lz −2.9
FVC2.97 Lz −0.9
Post-BD change+8%below threshold
Obstructive pattern, moderate. No significant bronchodilator response.
  1. FEV1/FVC z-score below −1.645 → obstruction
  2. FEV1 z between −2.5 and −4 → moderate
  3. Change under 10% of predicted → no significant response
Suggested interpretation · awaiting doctor sign-off

Example values for illustration. Not patient data.

  1. Acquisition time of 15–30 seconds of tidal breathing per recording, from the alveoflow FOT System specification. Applies to alveoflow Pro and alveoflow Neo.
  2. FHIR R4 and HL7 v2 export from the alveoflow FOT System specification. ABDM integration supported.
  3. CDSCO Class B under MDR 2017. ISO 13485 and MDSAP as stated on alveo.fit. alveoflow: US 510(k) submission pending; not cleared for sale in the United States. alveoair is US FDA 510(k) cleared (K222525, August 2023).
  4. Screens show example data and do not represent a real patient. Interpretation is the responsibility of the treating clinician.